Livia

Rapid, Nearly Instant Relief from Menstrual Pain.

Livia pioneered an FDA-cleared tech, secured by 8 patents, that reduces menstrual pain in 30–60 seconds using low-intensity electrical frequencies. Trusted by hundreds of thousands globally, we’re launching our 2nd-gen model and prepping for an IPO.

385% of funding target

3

Units left

$20,000

Minimum investment

11

Days to go

By:

Overfunding

Investment type:

Convertible

Company Stage:

Round A

Category:

Digital Health

Highlights

Pitch

Team

חן נחום, CEO

שניר הרמן

ג'ון פול

עדי שוחט

טל צוק

צבי נחום

איילת הרגש

סמדר לנדאו

Financial data

Updates

Currently there are no updates in this pitch

The financing rounds, made through the ExitValley platform, are in accordance with a model of statutory exemption from publishing a prospectus pursuant to sections 15A(A)(1) and 15A(A)(7) of the Israeli Securities Law - 1968.
Under this model, the disclosure of detailed information on the company and information about the investment in each round of financing are limited to not more than 35 investors, who are not qualified investors, and the round of financing is not in the format of an offering arrangement ("רכז הצעה"), as defined in the Securities Law.

Your request for full viewing of this campaign has been successfully submitted, a company representative will contact you shortly An initial password was sent to the email address you submitted, it can be changed at any time

Your request for full viewing of this campaign has been successfully submitted, a company representative will contact you shortly

Livia

Rapid, Nearly Instant Relief from Menstrual Pain.

385% of funding target

3

$20,000